STOCK TITAN

Kingdon Capital exits Scynexis (SCYX) stake in amended 13G/A filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

SCYNEXIS, Inc. received an amended Schedule 13G/A from Kingdon Capital Management, L.L.C. and Mark Kingdon reporting that they now beneficially own 0 shares of the company’s common stock, or 0% of the class, as of December 31, 2025.

They report no sole or shared voting or dispositive power over any SCYNEXIS shares and indicate ownership of 5 percent or less of the class. They also certify that any securities previously held were not acquired to change or influence control of the company.

Positive

  • None.

Negative

  • None.

Insights

Kingdon Capital and Mark Kingdon report a reduced SCYNEXIS stake down to 0% ownership.

The filing shows Kingdon Capital Management, L.L.C. and Mark Kingdon now report beneficial ownership of 0 shares, or 0% of SCYNEXIS common stock as of December 31, 2025. They also show no voting or dispositive power over any shares.

This indicates that a previously reportable holder has effectively exited its position or no longer meets reporting thresholds. The certification states the securities were not acquired or held to change or influence control, which aligns this with a passive, non-control-oriented investment stance rather than an activist position.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



KINGDON CAPITAL MANAGEMENT, L.L.C.
Signature:By: /s/ Richard Weinstein
Name/Title:Richard Weinstein, Chief Operating Officer & General Counsel
Date:02/17/2026
MARK KINGDON
Signature:By: /s/ Mark Kingdon
Name/Title:Mark Kingdon
Date:02/17/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

FAQ

What does the SCYNEXIS (SCYX) Schedule 13G/A Amendment No. 3 report?

The amendment reports that Kingdon Capital Management, L.L.C. and Mark Kingdon now beneficially own 0 shares, or 0%, of SCYNEXIS common stock. It updates their ownership status as of December 31, 2025, replacing any prior reportable stake.

Who are the reporting persons in the SCYNEXIS (SCYX) Schedule 13G/A?

The reporting persons are Kingdon Capital Management, L.L.C., organized in Delaware, and Mark Kingdon, a United States citizen. Both jointly report on their beneficial ownership, voting power, and dispositive power over SCYNEXIS common stock.

How many SCYNEXIS (SCYX) shares does Kingdon Capital report owning in this filing?

Kingdon Capital Management, L.L.C. reports beneficial ownership of 0 SCYNEXIS common shares. It also reports 0 sole voting power, 0 shared voting power, and 0 dispositive power, reflecting a complete absence of reportable holdings.

What percentage of SCYNEXIS (SCYX) does Mark Kingdon report owning?

Mark Kingdon reports beneficial ownership of 0% of SCYNEXIS’s common stock. He indicates 0 shares beneficially owned and no sole or shared power to vote or dispose of any SCYNEXIS shares as of the reported date.

What is the significance of the ‘ownership of 5 percent or less’ statement for SCYNEXIS (SCYX)?

The filing indicates “ownership of 5 percent or less of a class,” confirming that the reporting persons are below the 5% threshold. This explains why they now report 0% beneficial ownership and no longer appear as significant shareholders.

Do Kingdon Capital and Mark Kingdon seek to influence control of SCYNEXIS (SCYX)?

The certification states the securities were not acquired and are not held to change or influence control of SCYNEXIS. It also notes they are not participating in any transaction with that purpose, aside from activities related to nominations under the specified rule.

Who signed the SCYNEXIS (SCYX) Schedule 13G/A on behalf of Kingdon Capital?

Richard Weinstein, Chief Operating Officer and General Counsel, signed for Kingdon Capital Management, L.L.C., and Mark Kingdon signed individually. They certify that the information in the statement is true, complete, and correct to the best of their knowledge.

Scynexis

NASDAQ:SCYX

SCYX Rankings

SCYX Latest News

SCYX Latest SEC Filings

SCYX Stock Data

34.15M
40.41M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
JERSEY CITY